LENSAR, Inc. LNSR
Set alert
5.65 USD -0.20 -3.34%
As of Nov 2, 1:14 PM ET
5.64 Day range 5.86
4.95 52-week range 12.94
- YTD
- -51.46%
- 1 year
- -54.11%
- Open
- 5.84
- Prev close
- 5.84
- Mkt cap
- 69.35M
- Vol
- 40.72K
- Avg vol
- 104.15K
- EPS
- 0.18
- P/E
- 31.36
- Div yield
- 0.00%
More statistics
- Low
- 5.64
- High
- 5.86
- Forward P/E
- -12.18
- Beta
- 0.58
- Short ratio
- 1.20
- Inst. own
- 42.42%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.72
- 200-d avg
- 4.84
- 1y target
- 11.00
2Y chart
Events in this range
- Nov 7, 2024Earnings: -0.13; estimate 0; surprise —%
Signals (109)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 21, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| RSI: Overbought | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
| RSI: Oversold | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| RSI: Oversold | Apr 24, 2026 | 6 months ago |
| RSI: Oversold | Apr 21, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 7 months ago |
| RSI: Oversold | Mar 17, 2026 | 7 months ago |
| RSI: Oversold | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 6, 2026 | 8 months ago |
| SMA: Bearish | Mar 6, 2026 | 8 months ago |
| SMA: Bullish | Mar 5, 2026 | 8 months ago |
| MACD: Buy Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Mar 3, 2026 | 8 months ago |
| SMA: Bearish | Feb 26, 2026 | 8 months ago |
| SMA: Bullish | Feb 25, 2026 | 8 months ago |
| SMA: Bearish | Feb 17, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 9 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 9 months ago |
| SMA: Bullish | Jan 30, 2026 | 9 months ago |
| SMA: Bearish | Jan 29, 2026 | 9 months ago |
| SMA: Bullish | Jan 23, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 16, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| SMA: Bearish | Dec 5, 2025 | 11 months ago |
| SMA: Bullish | Dec 4, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 24, 2025 | 11 months ago |
| RSI: Oversold | Nov 20, 2025 | 11 months ago |
| RSI: Oversold | Nov 14, 2025 | 11 months ago |
| RSI: Oversold | Nov 10, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 7, 2025 | 12 months ago |
| SMA: Bearish | Nov 6, 2025 | 12 months ago |
| SMA: Bullish | Nov 5, 2025 | 12 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Oct 31, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 20, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Oct 3, 2025 | 1 year ago |
| SMA: Bullish | Oct 2, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 26, 2025 | 1 year ago |
| SMA: Bearish | Sep 24, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 12, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 11, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| SMA: Bullish | Aug 5, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| SMA: Bearish | Jul 22, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 26, 2025 | 1 year ago |
| RSI: Oversold | Jun 10, 2025 | 1 year ago |
| RSI: Oversold | Jun 5, 2025 | 1 year ago |
| MACD: Sell Signal | May 21, 2025 | 1 year ago |
| SMA: Bearish | May 15, 2025 | 1 year ago |
| SMA: Bullish | May 14, 2025 | 1 year ago |
| MACD: Buy Signal | May 14, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| MACD: Sell Signal | May 2, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 30, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 28, 2025 | 1 year ago |
| RSI: Overbought | Feb 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 11, 2025 | 1 year ago |
| RSI: Overbought | Feb 4, 2025 | 1 year ago |
| RSI: Overbought | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 8, 2025 | 1 year ago |
| RSI: Overbought | Dec 24, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 23, 2024 | 1 year ago |
Key statistics
- Market cap
- 100.47M
- Enterprise value
- 87.01M
- Trailing P/E
- 0.00
- Forward P/E
- -12.18
- PEG ratio
- 0.00
- Price / sales
- 2.06
- Price / book
- 4.42
- EPS (TTM)
- -1.46
- Beta
- 0.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -34.03%
- Revenue (TTM)
- 48.87M
- Revenue growth
- 38.20%
- Free cash flow
- 0
- Total cash
- 18.08M
- Total debt
- 1.89M
- Return on equity
- -38.38%
- Shares outstanding
- 11.61M
- Short % of float
- 0.61%
- 50-day average
- 6.72
- 200-day average
- 4.84
Analyst view
Consensus: none
Price target (mean) 11.00 +94.9% upside
Now 5.65
- Target (low)
- 10.00
- Target (mean)
- 11.00
- Target (high)
- 12.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.18.
Financials — quick view
LNSR Revenue — quarterly 16.50M
LNSR Net income — quarterly 3.54M
LNSR EPS — quarterly 0.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.00 | -0.13 | — | — |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | -0.53 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.19 | — | — |
| Mar 4, 2024 | Dec 1, 2023 | 0.00 | -0.35 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -0.23 | — | — |
| Aug 9, 2023 | Jun 1, 2023 | 0.00 | -0.81 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 19, 2024 | Lake Street | init | — | Buy |
| Nov 22, 2021 | BTIG | init | — | Buy |
| Feb 24, 2021 | SVB Leerink | init | — | Outperform |
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- lensar.com
News
- Cedar Grove Capital Q3 2026 Portfolio Update
- LUCID CAPITAL MARKETS Initiates Coverage On LENSAR with Buy Rating, Announces Price Target of $11
- BTIG Maintains Buy on LENSAR, Raises Price Target to $10
- LENSAR Q2 Earnings Call Highlights
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- LENSAR, Inc. (LNSR) Q2 2026 Earnings Call Transcript
- LENSAR Q2 2026 Earnings Call: Complete Transcript
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- LENSAR Q2 EPS $0.10 Beats $(0.17) Estimate, Sales $16.495M Beat $14.650M Estimate
- LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
Your note
Sign in to keep a note on LNSR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CONNAUGHTON ALAN B. | Chief Operating Officer | Stock Award(Grant) | May 5, 2024 | 324,489 |
| CURTIS NICHOLAS T | Chief Executive Officer | Stock Award(Grant) | May 5, 2024 | 864,436 |
| ELLIS THOMAS B. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 6, 2024 | 1,131,880 |
| HAMMER TODD B. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | May 6, 2024 | 1,131,880 |
| LINDSTROM RICHARD L | Director | Stock Award(Grant) | May 6, 2024 | 239,036 |
| LINK WILLIAM J | Director | Stock Award(Grant) | May 6, 2024 | 543,267 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Park West Asset Management LLC | 8.52% | 989,945 | 8.56M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 5.59% | 648,959 | 5.61M | Sep 29, 2024 |
| Brandes Investment Partners L.P. | 3.82% | 443,398 | 3.84M | Sep 29, 2024 |
| Vanguard Group Inc | 3.73% | 433,474 | 3.75M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 2.65% | 307,945 | 2.66M | Sep 29, 2024 |
| DCF Advisers, LLC | 2.07% | 240,600 | 2.08M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.44% | 282,930 | 2.45M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.15% | 133,235 | 1.15M | Sep 29, 2024 |
| DFA U.S. Targeted Value Portfolio | 1.00% | 116,724 | 1.01M | Jul 30, 2024 |
| DFA U.S. Small Cap Series | 0.88% | 102,775 | 889.00K | Jul 30, 2024 |
| DFA U.S. Small Cap Value Series | 0.86% | 100,409 | 868.54K | Jul 30, 2024 |
| Brandes Small Cap Value Fund | 0.81% | 94,178 | 814.64K | Sep 29, 2024 |